Related Experiment Video
Updated: May 25, 2026

Inducing Plasticity of Astrocytic Receptors by Manipulation of Neuronal Firing Rates
Published on: March 20, 2014
[Effects of receptor interacting protein 140 on the biological activity of glia cells]
Li-na Xie1, Wei-dong Yu, Rong Liang
1Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China.
Objective:
To explore the effects of receptor interacting protein (RIP) 140 gene overexpression upon the in vitro proliferation, apoptosis, invasion and migration of microglioma cells.
Methods:
The BV-2 RIP140 overexpression model (BV-2-1) was constructed by Lipofection and G418 selection, then validated by real-time PCR and Western blotting. The proliferation, apoptosis, invasion and migration potencies were compared between BV-2-1 and its parents by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT) assay, flow cytometry and Transwell chamber.
Results:
The BV-2-1 model was successfully constructed. Compared to those of the BV-2 group, the RIP140 mRNA and protein expression levels of BV-2-1 were markedly higher than those of the BV-2 group (t = 49.794, P < 0.01). MTT assay showed that the absorbance values in the BV-2 group were 1.157 ± 0.013, 1.679 ± 0.005 and 2.609 ± 0.008 at 24, 48, and 72 hours respectively. And those were 0.929 ± 0.013, 1.188 ± 0.008 and 1.528 ± 0.012 in the BV-2-1 group respectively. The proliferation at the time points of 48 and 72 hours of the BV-2-1 group were significantly lower than that of the BV-2 group (t = 6.058 and 9.245, both P < 0.01). Annexin-V staining showed that there were significant differences in the apoptosis rates between the BV-2 and BV-2-1 cells [(5.35 ± 0.23)% vs (3.46 ± 0.45)%, t = 6.619, P = 0.003)]. Transwell assay showed that the invaded cell number of the BV-2-1 group was 166 ± 43. And it was obviously higher than that of the BV-2 group (93 ± 32, t = 3.403, P = 0.007). Transwell assay also showed that the migrated cell number of BV-2 cells was 101 ± 25. And the migration potency of the BV-2-1 group (202 ± 50) was significantly stronger than that of the BV-2 group (t = 4.104, P = 0.002).
Conclusion:
RIP140 effectively inhibits the proliferation and facilitates the apoptosis of microglioma cells. And it may effectively facilitate the in vitro invasion and migration of microglioma cells.
Insights
Receptor interacting protein 140 (RIP140) gene overexpression inhibits microglioma cell proliferation and promotes apoptosis. However, RIP140 may enhance microglioma cell invasion and migration in vitro.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Context:
- Microglioma, a primary brain tumor, arises from glial cells.
- Understanding the molecular mechanisms regulating microglioma progression is crucial for developing targeted therapies.
Purpose:
- To investigate the role of receptor interacting protein 140 (RIP140) gene overexpression in regulating the in vitro behavior of microglioma cells.
- To assess the impact of RIP140 on proliferation, apoptosis, invasion, and migration of microglioma cells.
Summary:
- A BV-2 microglioma cell model with RIP140 overexpression (BV-2-1) was established and validated.
- RIP140 overexpression significantly reduced microglioma cell proliferation and increased apoptosis.
- Conversely, RIP140 overexpression markedly enhanced the invasion and migration capabilities of microglioma cells in vitro.
Impact:
- RIP140 acts as a potential tumor suppressor by inhibiting proliferation and inducing apoptosis in microglioma cells.
- The pro-invasive and pro-migratory effects of RIP140 suggest a complex role in tumor progression, warranting further investigation.
- Findings provide insights into RIP140's multifaceted influence on microglioma, potentially guiding future therapeutic strategies.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Glial Cells
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

